Research News and Research

RSS

NICE suggests bortezomib, thalidomide for multiple myeloma patients

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance which recommends the drugs bortezomib and thalidomide as first-line therapies for some patients with multiple myeloma, a type of cancer that affects cells in the bone marrow.

27 Aug 2010

Lysozyme can protect anthrax contamination in processed foods: Study

An antibacterial enzyme found in human tears and other body fluids could be applied to certain foods for protection against intentional contamination with anthrax, scientists reported here today at the 240th National Meeting of the American Chemical Society (ACS).

27 Aug 2010

New vibration technology to reduce stubborn stomach fat

For millions of dieters it seems impossible to lose belly fat no matter however carefully they watch what they eat or how many sit-ups they do. Some people give up and blame it on genetics, metabolism or body type and simply accept it as a fact of life. For whatever the reason, many Americans discover that stubborn fat around the stomach and love handles will not melt away despite their best efforts. Now a fitness research company says there is an effective way to win the battle of the bulge without special diets, drinks or difficult exercises.

27 Aug 2010

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

The Department of Veterans Affairs is partnering with the National Institutes of Health (NIH) to award $6 million in grants for research examining the link between substance abuse and military deployments and combat-related trauma.

26 Aug 2010

China PharmaHub signs distribution agreement for radioactive glass sphere treatment for liver cancer

China PharmaHub Corp. ("PharmaHub"), which has recently merged with World Wide Relics which has changed its name to China PharmaHub Corp, and is in the process of obtaining approval from FINRA to trade under its new name with a new symbol, announced today that it has signed an Exclusive Distribution Agreement ("Agreement") with a world leader in precision glass technology which can be utilized to manufacture high precision radioactive glass spheres that emit alpha, beta or gamma radiation, either individually or in combination, for the treatment of malignant tumors of the liver.

26 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

Laxai Pharma reports $1,735K revenue for first six months

Laxai Pharma, Ltd. an international pharmaceutical contract research organization ("CRO"), is pleased to announce that it has published its second quarter results last week for the period ended as of June 30, 2010.

26 Aug 2010

AARP Report finds increase in brand-name drug costs outstrips inflation

"Retail prices for some of the most widely used brand-name prescription drugs shot up more than 8 percent in 2009, even as inflation plummeted to a record low, according to a new AARP analysis of retail drug price trends released today.

26 Aug 2010

Health on the Hill – August 25, 2010

In this Kaiser Health News discussion, KFF's Jackie Judd talks with Time's Michael Crowley about recent news during this August recess. Lawmakers are finding the electorate to be quieter on the topic of health care than they were during last summer's heated town hall meetings.

26 Aug 2010

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.

26 Aug 2010

BioTrends Research Group report provides in-depth view of kidney transplantation market

BioTrends Research Group, Inc. recently published its TreatmentTrends: Kidney Transplantation report. This report is based on online survey results from over 150 physicians (general nephrologists, transplant nephrologists and transplant surgeons). It provides an in-depth view of the kidney transplantation market, including the roles of the various specialties, promotional efforts and sales representative messaging, barriers to kidney transplant, the care of post-transplant patients, and current and projected use of immunosuppressive agents for induction, maintenance and acute rejection.

26 Aug 2010

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

OXIS INTERNATIONAL, INC. is proud to announce that it has initiated active planning for the First World Congress on Ergothioneine, to be held in Los Angeles, California in July 2011 (the specific date will be announced at a later date).

26 Aug 2010

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

Sermo, the world's largest online community for physicians, today announced a free Sermo Report titled, "FDA Committee Recommends Approval for Ticagrelor." The report covers physician opinions about the introduction of an investigational oral antiplatelet treatment for acute coronary syndrome.

26 Aug 2010

NeoPharm second-quarter net loss decreases to $0.8 million

NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.

26 Aug 2010

DePuy Orthopaedics announces voluntary recall of ASR XL Acetabular and Hip Resurfacing systems

DePuy Orthopaedics, Inc., announced it is voluntarily recalling the ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System used in hip replacement surgery due to the number of patients who required a second hip replacement procedure, called a revision surgery.

26 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

26 Aug 2010

New article examines education practices, priorities for deaf-blind children

Deaf-blind children can be isolated and disconnected from people and activities. Without individualized support, they cannot access visual and auditory information and often complete school unable to seek future education, employment, or independent living. Providing appropriate special education and related services for deaf-blind children poses unique challenges.

26 Aug 2010

Part of U.S. aid package for Pakistan will be redirected to fund flood rebuilding, USAID Administrator says

Part of the previously planned $7.5 billion U.S. aid package for Pakistan will be redirected to flood rebuilding projects, said USAID Administrator Rajiv Shah, the Associated Press reports. Shah also "warned that other nations would only contribute money if Islamabad could ensure it would be well spent."

26 Aug 2010

Tobacco companies use web 2.0 media to get around marketing restrictions

Tobacco companies may be using web 2.0 media, such as YouTube, to market their products to young people, so getting round marketing restrictions for tobacco content in place elsewhere, suggests research published online in Tobacco Control.

26 Aug 2010

MIT's Technology Review announces 2010 TR35 annual list of young innovators

MIT's Technology Review today announced the 2010 TR35, its annual list of 35 outstanding men and women under the age of 35 who exemplify the spirit of innovation in business and technology. This year's winners have created innovations over a wide variety of fields, including energy, biomedicine, communications, IT, transportation, and the Web.

26 Aug 2010

Research News and Research

NICE suggests bortezomib, thalidomide for multiple myeloma patients

Lysozyme can protect anthrax contamination in processed foods: Study

New vibration technology to reduce stubborn stomach fat

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

China PharmaHub signs distribution agreement for radioactive glass sphere treatment for liver cancer

Aethlon Medical receives approval for Chronic HCV Infection treatment

Laxai Pharma reports $1,735K revenue for first six months

AARP Report finds increase in brand-name drug costs outstrips inflation

Health on the Hill – August 25, 2010

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

BioTrends Research Group report provides in-depth view of kidney transplantation market

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

NeoPharm second-quarter net loss decreases to $0.8 million

DePuy Orthopaedics announces voluntary recall of ASR XL Acetabular and Hip Resurfacing systems

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

New article examines education practices, priorities for deaf-blind children

Part of U.S. aid package for Pakistan will be redirected to fund flood rebuilding, USAID Administrator says

Tobacco companies use web 2.0 media to get around marketing restrictions

MIT's Technology Review announces 2010 TR35 annual list of young innovators

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence